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Salmonella occupies a vacuolar compartment inside
cells of its host. Recent studies have shown that the
fate of this vacuole is different in various cell types,
and that the outcome of colonization is determined
by both the infecting bacterium and defense mech-
anisms of the host cell.
Many pathogenic microbes establish infection by col-
onizing and often entering cells of their host. Each
invasive pathogen has its own strategy for intracellu-
lar survival. For example, some pathogens escape the
phagosome and replicate in the nutrient rich cytosol,
while others alter the trafficking of their vacuolar niche
to avoid antimicrobial agents elsewhere in the cell [1].
Salmonella provides a well-studied example of the
latter strategy, altering endocytic trafficking of its
vacuole to survive and replicate in host cells during
disease. A number of recent studies have revealed how
Salmonella can occupy different intracellular niches
during colonization of different cell types, adding
further insight into our understanding of intracellular
parasitism (Table 1).
Trafficking of the Salmonella vacuole
The estimated 2200 different serovars of Salmonella
can infect most animals, with the outcome of infection
determined by the genetic complement and fitness of
both the infecting Salmonella serovar and its host. Sal-
monella enterica serovar Typhimurium (S. Typhimurium)
is a leading cause of gastroenteritis (food poisoning)
in humans and causes a systemic disease resembling
typhoid fever in genetically susceptible mice, making it
a powerful model for the study of both diseases.
Infections are initiated by consumption of contami-
nated food or water, after which the bacteria breach
the epithelial barrier of the small intestine and enter
the bloodstream to colonize the liver, spleen and other
tissues. During this conquest of the host, S. Typhimurium
occupies an intracellular niche and is protected from
cell-impermeant antibiotics [2]. How this pathogen can
perform such a feat during its interaction with many
diverse cell types of the host is an important and hotly
debated question.
As early stages of infection involve interaction with the
intestinal epithelium, many investigators have focused
on interactions of S. Typhimurium with epithelial cell
lines in vitro. These studies have revealed the mecha-
nisms by which this pathogen can invade these 
non-phagocytic cells in a manner dependent on
rearrangements of the actin cytoskeleton [3]. Follow-
ing invasion, the bacteria can survive and replicate
within a membrane-bound compartment, the Salmo-
nella-containing vacuole (SCV). While it was previously
thought that fusion of the SCV with late endocytic
compartments was blocked, a recent study has demon-
strated that fusion is merely delayed [4]. Indeed,
several hours after infection, the SCV fuses exten-
sively with late endosomes, causing it to elongate into
tubules known as Salmonella-induced filaments (Sifs).
This dramatic phenotype is dependent on SifA, a viru-
lence protein of S. Typhimurium that is translocated
from the bacteria into host cells by a needle-like
protein delivery apparatus called the SPI-2 type III
secretion system. Sifs are unique to Salmonella infec-
tion of epithelial cells in vitro, though their role during
infection in vivo remains unknown.
During systemic phases of disease in mice,
S. Typhimurium is found in macrophages in both the
liver [5] and spleen [6]. Maintenance of the SCV is
accomplished both in vitro [7] and in vivo [6] by 
the actions of SifA, which plays a major role in viru-
lence as loss of the SCV results in death of the bacte-
ria in the macrophage cytosol. While SifA keeps
S. Typhimurium within a vacuolar niche, other factors
alter the fate of this compartment. For example, the
SPI-2 type III secretion system has recently been
shown to block assembly and delivery of the NADPH
oxidase, a multiprotein superoxide generating
complex that plays a major role in innate host defense,
to the SCV [8,9]. By preventing delivery of the NADPH
oxidase, intracellular S. Typhimurium is able to mini-
mize its exposure to toxic free radicals of oxygen.
S. Typhimurium has also been shown to block fusion
of the SCV with lysosomes in macrophages [10, 11],
an observation that now provides a contrast to SCV
trafficking in epithelial cells [4]. These studies reveal
the complexity with which S. Typhimurium can alter
SCV integrity and trafficking within a given host cell,
though the mechanisms by which this occurs remain
undetermined.
Dendritic cells are antigen-presenting cells located
in central lymphoid organs and Peyer’s patches of 
the intestine. S. Typhimurium can occupy this cell type
in the mouse model of infection [12], though in vitro
studies suggest that replication in this cell type is
limited [13,14]. Interestingly, survival in dendritic cells
does not require virulence factors that are essential for
macrophage colonization, suggesting that different
effectors are involved [14]. As in other cell types, the
SCV consists of a single limiting membrane and is dis-
tinct from the multilamellar compartments containing
major histocompatability complex (MHC) class II
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proteins, which are characteristic of dendritic cells.
Unlike other cells, the SCV in dendritic cells does not
acquire lysosomal glycoproteins [13], a feature unique
to this cell type.
SCV trafficking has also been examined in a human
melanoma line (MelJuSo) and melanocytes [15].
Melanocytes are located in the epidermis and come
into contact with pathogens that penetrate the skin
barrier. S. Typhimurium cells invade and survive within
MelJuSo cells where, much as in dendritic cells, they
undergo limited replication. Acquisition of many endo-
cytic markers by the SCV — including EEA1, CD63
and the vacuolar ATPase — occurs in a manner
similar to that seen in epithelial cells. Unlike in epithe-
lial cells, however, in MelJuSo cells acquisition of the
lysosomal glycoprotein Lamp-1 is delayed and Rab7
is maintained on the SCV for two hours post-infection.
In epithelial cells, Rab7 is rapidly recruited and then
recycled during the first hour post-infection [16]. Col-
onization of melanoma cells (and the MelJuso cell line)
leads to a dramatic elongation of S. Typhimurium and
a block in bacterial septation [15]. Elongation allows
the release of bacteria from the SCV to the extracellu-
lar space. Whether this represents a bacterial tactic
for survival and dissemination or a host killing mecha-
nism remains to be determined.
Host factors alter SCV trafficking
Most studies of S. Typhimurium infection have 
been performed with genetically susceptible mice
lacking the natural-resistance-associated macrophage
protein-1 (Nramp-1). This protein plays a major role in
restricting intracellular replication of a number of
pathogens, including S. Typhimurium [17]. Nramp-1 is
capable of transporting divalent cations across the
SCV, and has recently been shown to alter intracellu-
lar trafficking of S. Typhimurium in macrophages [18].
Expression of Nramp-1, either in primary macrophages
from mice or in a macrophage cell line, increases the
percentage of SCVs positive for the mannose 6-phos-
phate receptor, a marker of late endosomes. A similar
effect on fusion with endosomes containing internal-
ized fluorescent markers is also observed. These find-
ings suggest that Nramp-1 counteracts the ability of
S. Typhimurium to block SCV fusion with late endocytic
compartments, and promotes degradation of this
pathogen. The mechanisms by which Nramp-1 achieves
this are not known, but likely include its pleiotropic
effects on macrophage activation [17] and its ability to
remove divalent cations from the SCV, which are
essential for bacterial survival and replication.
Bacterial determinants of intracellular replication
S. Typhimurium does not replicate in fibroblasts [19],
suggesting that this cell type is capable of restricting
intracellular replication by this pathogen. Exciting new
results have now suggested that it may, in fact, be the
bacteria that dictate when and in which cell types
replication will occur. Cano et al. [20] have reported
the isolation of a variety of S. Typhimurium mutants
that exhibit increased proliferation within NRK cells, a
rat kidney fibroblast cell line. Surprisingly, these strains
harbor mutations in many of the key S. Typhimurium
virulence regulators required for systemic disease in
animal models and for normal levels of replication in
mouse macrophages. This suggests that S. Typhimurium
uses these regulatory elements to sense which cell
type it occupies, adjusting its own replication accord-
ingly. The mechanisms by which S. Typhimurium con-
trols its own replication in fibroblasts remain unknown,
and it remains to be determined if intracellular traf-
ficking of the SCV plays a role. Fibroblasts may
provide S. Typhimurium with protection from the host
immune system, while creating a reservoir of intracel-
lular bacteria with which to mediate persistent infec-
tion. This represents the first example of an intracellular
bacterial pathogen capable of attenuating its own
replication within a eukaryotic cell.
Biological significance
Extensive study of S. Typhimurium has revealed how
a single pathogen can occupy a unique intracellular
compartment inside different cell types of its host.
This reflects a complex adaptation to the infection of
multicellular animals, and a complete virulence strat-
egy from entry to exit. These findings force us to think
differently about intracellular pathogenesis, and the
question of whether other intracellular pathogens
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Table 1. Intracellular trafficking of S. Typhimurium in various cell types.
Cell type Salmonella vacuole Replication Bacterial
traffic morphology
Epithelial cells Rapid Lgp acquisition In vacuole and cytosol Typical rod shape
Delayed fusion with LE/Lys Some elongation at late times
Elongation into tubules (Sifs)
Macrophages Acquire Lgp but block LE/Lys fusion In vacuole not cytosol Typical rod shape
Block NADPH oxidase delivery Some elongation at late times
Actively maintain SCV membrane
Dendritic cells No Lgp acquisition Restricted Typical rod shape
Melanocytes Lgp, Rab7, CD63, vATPase Restricted Non-septate and filamentous
No cathepsin D delivery
Fibroblasts Acquire Lgp Restricted* Septate and filamentous or round
Abbreviations: LE/Lys, late endosome/lysosome; Lgp, lysosomal glycoproteins; SCV, Salmonella-containing vacuole; Sifs, Salmonella-induced
filaments; vATPase, vacuolar type H+ATPase. *Restriction of wild type bacteria, not those with genetic deletion of some regulatory systems.
occupy unique niches in different cell types of their
host must now be addressed.
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